MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$304,393
Net Income
-$19,445,607
Net Profit Margin
-6388.32%
EPS
-$34
Unit: Dollar
Revenue Breakdown
Revenue from contract with custo...
Revenue from contract with custo...
Revenue from contract with custo...
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2025-06-30
2025-03-31
2024-12-31
2024-09-30
Total revenues
304,393
983,374
1,196,617
1,038,863*
Cost of product revenues
299,263
612,527
512,510
757,680*
Gross profit
5,130
370,847
684,107
281,183*
Selling, general and administrative
2,930,627
2,983,284
2,633,098
3,411,212*
Research and development
768,563
849,358
1,015,010
854,657*
The amount of unrealized loss on change in fair value of warrants
-
-
-
-98,500*
Total operating expenses
3,699,190
3,832,642
3,648,108
4,265,869*
The amount of loss from issuance of warrants
-
-
-
408,441.75*
Loss from operations
-3,694,060
-3,461,795
-2,964,001
-3,984,686*
Represents of transaction cost allocated to warrant liabilities
-
-
-
-158,299.5*
Other expense, net
-531
-3,095
-20,152
-8,574*
Interest income
40,267
60,340
71,440
67,416*
Unrealized loss on change in fair value of warrants classified as a liability
-6,410
-68,430
-244,000
8,220,539*
(loss) income before provision for income taxes
-3,647,914
-3,336,120
-2,668,713
-12,811,624.25*
Net loss from continuing operations
-3,647,914
-
-
-
Income tax expense (benefit)
-
-
-
0*
Net loss from discontinued operations, net of tax
-336,195
-
-
-
Net (loss) income
-3,984,109
-3,336,120
-2,668,713
-12,811,624.25*
Less net loss attributable to noncontrolling interest
-38,746
-31,945
-29,301
-4,900*
Net (loss) income attributable to applied dna sciences, inc
-3,945,363
-3,304,175
-2,639,412
-12,806,724.25*
Deemed dividend related to warrant modifications
15,500,244
23,919,429
14,907,223
58,271.75*
Net (loss) income attributable to common stockholders
-19,445,607
-27,223,604
-17,546,635
-12,864,996
Basic EPS
-34
-15.35
-0.56
-3.284
Diluted EPS
-34
-15.35
-0.56
-3.284
Basic Average Shares
572,018
1,773,086
31,518,861
3,917,791
Diluted Average Shares
572,018
1,773,086
31,518,861
3,917,791
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net (loss) income
attributable to common...
-$19,445,607
(-1134.45%↓ Y/Y)
Deemed dividend
related to warrant...
$15,500,244
Net (loss) income
attributable to applied dna...
-$3,945,363
(-309.88%↓ Y/Y)
Less net loss
attributable to...
-$38,746
(-27.90%↓ Y/Y)
Net (loss) income
-$3,984,109
(-315.42%↓ Y/Y)
Net loss from
continuing operations
-$3,647,914
Net loss from
discontinued operations, net...
-$336,195
Revenue from contract
with customer,...
$160,999
Revenue from contract
with customer,...
$91,324
Revenue from contract
with customer,...
$52,070
(loss) income before
provision for income taxes
-$3,647,914
(-297.24%↓ Y/Y)
Interest income
$40,267
(10.94%↑ Y/Y)
Unrealized loss on change in
fair value of...
-$6,410
(99.88%↑ Y/Y)
Total revenues
$304,393
(-61.83%↓ Y/Y)
Loss from operations
-$3,694,060
(-10.38%↓ Y/Y)
Gross profit
$5,130
(-97.91%↓ Y/Y)
Other expense, net
-$531
(-425.74%↓ Y/Y)
Cost of product
revenues
$299,263
(-45.81%↓ Y/Y)
Total operating
expenses
$3,699,190
(2.99%↑ Y/Y)
Selling, general and
administrative
$2,930,627
(9.40%↑ Y/Y)
Research and development
$768,563
(-15.82%↓ Y/Y)
Buy us a coffee
APPLIED DNA SCIENCES INC (APDN)
APPLIED DNA SCIENCES INC (APDN)